PYXS · Pyxis Oncology, Inc.
$3.08
-0.04 (-1.28%)
At close · Aug 21
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern for one year from the date these unaudited condensed consolidated financial statements were issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$256.90M
Shares
83.41M
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
Model estimate
Expected Aug 14 short interest
as of Aug 14
4,556,759
+9.2% vs reported
Short Squeeze Score
75/100
Short interest 5.0% of shares — P74
Days to cover 4.2 — P61
Price vs VWAP +13.6% — P85
Short-volume trend +7.3% — P77
Short interest change +28.2% — P88
Worst FTD 0.07% of shares — P80
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-08-31
Scheduled
FINRA publishes Sep 10
|
— | — | — | — |
|
2026-08-14
Scheduled
FINRA publishes Aug 25
|
— | — | — | — |
| 2026-07-31 | 4,172,154 | 3,253,653 | +918,501 | 4.19 |
| 2026-07-15 | 3,253,653 | 2,289,798 | +963,855 | 3.11 |
| 2026-06-30 | 2,289,798 | 2,015,710 | +274,088 | 1.25 |
| 2026-06-15 | 2,015,710 | 1,741,743 | +273,967 | 4.85 |
| 2026-05-29 | 1,741,743 | 1,809,793 | -68,050 | 2.87 |
| 2026-05-15 | 1,809,793 | 1,986,201 | -176,408 | 2.11 |
| 2026-04-30 | 1,986,201 | 2,269,065 | -282,864 | 5.51 |
| 2026-04-15 | 2,269,065 | 2,660,931 | -391,866 | 5.64 |
| 2026-03-31 | 2,660,931 | 2,490,249 | +170,682 | 7.37 |
| 2026-03-13 | 2,490,249 | 2,525,155 | -34,906 | 7.70 |
| 2026-02-27 | 2,525,155 | 2,442,905 | +82,250 | 9.85 |
| 2026-02-13 | 2,442,905 | 2,386,094 | +56,811 | 3.78 |
| 2026-01-30 | 2,386,094 | 2,307,831 | +78,263 | 3.94 |
| 2026-01-15 | 2,307,831 | 1,733,403 | +574,428 | 1.20 |
| 2025-12-31 | 1,733,403 | 1,933,041 | -199,638 | 1.00 |
| 2025-12-15 | 1,933,041 | 4,523,744 | -2,590,703 | 3.00 |
| 2025-11-28 | 4,523,744 | 4,541,093 | -17,349 | 7.66 |
| 2025-11-14 | 4,541,093 | 4,361,521 | +179,572 | 4.79 |
| 2025-10-31 | 4,361,521 | 4,250,799 | +110,722 | 7.79 |
| 2025-10-15 | 4,250,799 | 4,131,340 | +119,459 | 3.91 |
| 2025-09-30 | 4,131,340 | 4,359,697 | -228,357 | 6.02 |
| 2025-09-15 | 4,359,697 | 4,334,176 | +25,521 | 4.16 |
| 2025-08-29 | 4,334,176 | 5,032,348 | -698,172 | 7.60 |
Showing 1–23 of 23 settlements
Key facts
CIK
1782223
CUSIP
747324101
13F (30d)
75 filings
75 filers
Visit website
Investor relations